A new study shows where in the US antivaxers are most likely to make measles great again, thanks to driving up nonmedical exemptions and driving down vaccine uptake.
A new study shows where in the US antivaxers are most likely to make measles great again, thanks to driving up nonmedical exemptions and driving down vaccine uptake.